Cargando…

ZMYND8 is a primary HIF coactivator that mediates breast cancer progression

Epigenetic regulator plays a pivotal role in breast cancer progression. We recently demonstrated that the epigenetic reader zinc finger MYND-type containing 8 (ZMYND8) mediates breast cancer progression and metastasis by activating hypoxia-inducible factor (HIF). This discovery provides new insights...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan, Wang, Yingfei, Luo, Weibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Author's Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149752/ https://www.ncbi.nlm.nih.gov/pubmed/30250924 http://dx.doi.org/10.1080/23723556.2018.1479619

Ejemplares similares

HIF-1 suppresses lipid catabolism to promote cancer progression
por: Zhang, Huafeng
Publicado: (2015)

ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells
por: Luo, Maowu, et al.
Publicado: (2022)

Regulation of ZMYND8 to Treat Cancer
por: Chen, Yun, et al.
Publicado: (2021)

Dysregulation of HIF2α and autophagy in renal cell carcinoma
por: Liu, Xian-De, et al.
Publicado: (2014)

CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
por: Mahmoud, Sahar, et al.
Publicado: (2012)

PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN
por: Gupta, Amit, et al.
Publicado: (2017)

Rapamycin: A rheostat for CD8(+) T-cell-mediated tumor therapy
por: Srivastava, Rupesh K., et al.
Publicado: (2012)

The human TLR4 variant D299G mediates inflammation-associated cancer progression in the intestinal epithelium
por: Cario, Elke
Publicado: (2013)

Neonatal Fc receptors for IgG drive CD8(+) T cell-mediated anti-cancer immunosurveillance at tolerogenic mucosal sites
por: Baker, Kristi, et al.
Publicado: (2014)

Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression
por: Escobar, Giulia, et al.
Publicado: (2014)

The dual role of IRF8 in cancer immunosurveillance
por: Schiavoni, Giovanna, et al.
Publicado: (2013)

CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2(+) breast carcinoma
por: Tardáguila, Manuel, et al.
Publicado: (2013)

Activation of cytomegalovirus-specific CD8(+) T-cell response by antibody-mediated peptide-major histocompatibility class I complexes
por: Schmittnaegel, Martina, et al.
Publicado: (2015)

New insights on the role of CD8(+)CD57(+) T-cells in cancer
por: Wu, Richard C., et al.
Publicado: (2012)

Altering the intratumoral localization of macrophages to inhibit cancer progression
por: Casazza, Andrea, et al.
Publicado: (2014)

The role of FOXP3 in disease progression in colorectal cancer patients
por: Grimmig, Tanja, et al.
Publicado: (2013)

Role of c-MYC in tumor-associated macrophages and cancer progression
por: Pello, Oscar M., et al.
Publicado: (2013)

Mechano-regulation of proline metabolism and cancer progression by kindlin-2
por: Guo, Ling, et al.
Publicado: (2019)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Novel function of STAT1 in breast cancer
por: Zhang, Ming
Publicado: (2013)

Stress-induced metastatic niches in breast cancer
por: Oskarsson, Thordur
Publicado: (2020)

New control of the senescence barrier in breast cancer
por: Costa, Tânia D. F., et al.
Publicado: (2020)

Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression
por: Di Carlo, Emma
Publicado: (2014)

Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis
por: Nemenoff, Raphael
Publicado: (2012)

COX2 regulation of breast cancer bone metastasis
por: Karavitis, John, et al.
Publicado: (2013)

Targeting dendritic cells in situ for breast cancer immunotherapy
por: Wang, Bei
Publicado: (2012)

Mammaglobin-A is a target for breast cancer vaccination
por: Kim, Samuel W., et al.
Publicado: (2016)

SRC promotes lipogenesis: implications for obesity and breast cancer
por: Lin, Shu-Yong, et al.
Publicado: (2021)

Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells
por: Végran, Frédérique, et al.
Publicado: (2013)

HIF repressors under chronic hypoxia
por: Luo, Weibo, et al.
Publicado: (2016)

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
por: Loi, Sherene
Publicado: (2013)

Role of plasmacytoid dendritic cells in breast cancer bone dissemination
por: Sawant, Anandi, et al.
Publicado: (2013)

Pre-surgical oncolytic virotherapy improves breast cancer outcomes
por: Mullins-Dansereau, Victor, et al.
Publicado: (2019)

Inhibition of RANK signaling as a potential immunotherapy in breast cancer
por: Gómez-Aleza, C, et al.
Publicado: (2021)

A role for EMT in CD73 regulation in breast cancer
por: Hasmim, Meriem, et al.
Publicado: (2022)

Long peptide-based cancer immunotherapy targeting tumor antigen-specific CD4(+) and CD8(+) T cells
por: Tomita, Yusuke, et al.
Publicado: (2013)

Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment
por: Ménétrier-Caux, Christine, et al.
Publicado: (2012)

Immune checkpoints: A therapeutic target in triple negative breast cancer
por: Chawla, Akhil, et al.
Publicado: (2014)

DNA methylation markers for breast cancer prognosis: Unmasking the immune component
por: Dedeurwaerder, Sarah, et al.
Publicado: (2012)

In Situ immunization by bispecific antibody targeted T cell therapy in breast cancer
por: Thakur, Archana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8tkmkggtg5lgq4i6mi1pbd0ogd